News

Back

Exothera announces the appointment of Hanna Lesch as Chief Technology Officer

October 27th 2021

BSCB Dev

Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), today announced that it has appointed Hanna Lesch as Chief  Technology Officer. Hanna’s extensive experience in cell and gene therapies will further extend Exothera’s capabilities in designing high-quality, cost-effective viral vector processes tailored to the requirements of its customers’ particular molecules.

Read Pdf